8372 Stock Overview
An investment holding company, engages in supplying of medical devices in Hong Kong. More details
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 0/6 |
Past Performance | 3/6 |
Financial Health | 6/6 |
Dividends | 2/6 |
My Notes
Capture your thoughts, links and company narrative
Grand Brilliance Group Holdings Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | HK$0.089 |
52 Week High | HK$0.12 |
52 Week Low | HK$0.081 |
Beta | 0.26 |
1 Month Change | -4.30% |
3 Month Change | 2.30% |
1 Year Change | -11.00% |
3 Year Change | 28.99% |
5 Year Change | -6.32% |
Change since IPO | -77.75% |
Recent News & Updates
Shareholders Will Probably Hold Off On Increasing Grand Brilliance Group Holdings Limited's (HKG:8372) CEO Compensation For The Time Being
Sep 04Grand Brilliance Group Holdings (HKG:8372) Strong Profits May Be Masking Some Underlying Issues
Jul 18Recent updates
Shareholders Will Probably Hold Off On Increasing Grand Brilliance Group Holdings Limited's (HKG:8372) CEO Compensation For The Time Being
Sep 04Grand Brilliance Group Holdings (HKG:8372) Strong Profits May Be Masking Some Underlying Issues
Jul 18Earnings Not Telling The Story For Grand Brilliance Group Holdings Limited (HKG:8372)
May 09Estimating The Intrinsic Value Of Grand Brilliance Group Holdings Limited (HKG:8372)
Oct 31Grand Brilliance Group Holdings (HKG:8372) Will Be Hoping To Turn Its Returns On Capital Around
Sep 21Grand Brilliance Group Holdings (HKG:8372) Will Want To Turn Around Its Return Trends
Oct 28Estimating The Intrinsic Value Of Grand Brilliance Group Holdings Limited (HKG:8372)
Aug 29A Look At The Fair Value Of Grand Brilliance Group Holdings Limited (HKG:8372)
Apr 29Returns On Capital At Grand Brilliance Group Holdings (HKG:8372) Paint A Concerning Picture
Mar 16Increases to Grand Brilliance Group Holdings Limited's (HKG:8372) CEO Compensation Might Cool off for now
Sep 10Weak Statutory Earnings May Not Tell The Whole Story For Grand Brilliance Group Holdings (HKG:8372)
Jul 02Grand Brilliance Group Holdings (HKG:8372) Could Be Struggling To Allocate Capital
May 11Is Now The Time To Put Grand Brilliance Group Holdings (HKG:8372) On Your Watchlist?
Mar 17We're Watching These Trends At Grand Brilliance Group Holdings (HKG:8372)
Feb 08Have Grand Brilliance Group Holdings Limited (HKG:8372) Insiders Been Selling Their Stock?
Dec 31Shareholder Returns
8372 | HK Healthcare | HK Market | |
---|---|---|---|
7D | -1.1% | 0.2% | 1.5% |
1Y | -11.0% | -16.9% | 20.6% |
Return vs Industry: 8372 exceeded the Hong Kong Healthcare industry which returned -16.6% over the past year.
Return vs Market: 8372 underperformed the Hong Kong Market which returned 22.4% over the past year.
Price Volatility
8372 volatility | |
---|---|
8372 Average Weekly Movement | 6.5% |
Healthcare Industry Average Movement | 8.2% |
Market Average Movement | 8.8% |
10% most volatile stocks in HK Market | 18.6% |
10% least volatile stocks in HK Market | 4.0% |
Stable Share Price: 8372 has not had significant price volatility in the past 3 months compared to the Hong Kong market.
Volatility Over Time: 8372's weekly volatility (7%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1997 | 50 | Bikie Wong | www.grandbrilliancegroup.com |
Grand Brilliance Group Holdings Limited, an investment holding company, engages in supplying of medical devices in Hong Kong. The company offers medical consumables; medical instruments; and medical equipment, as well as develops healthcare products. It also provides medical device solutions, such as market trend analysis, sourcing of medical devices, after-sale services, technical support and training services, medical devices leasing services, and quality assurance services; and maintenance and after sale services, as well as holds trademarks.
Grand Brilliance Group Holdings Limited Fundamentals Summary
8372 fundamental statistics | |
---|---|
Market cap | HK$71.20m |
Earnings (TTM) | HK$8.45m |
Revenue (TTM) | HK$82.29m |
8.4x
P/E Ratio0.9x
P/S RatioIs 8372 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
8372 income statement (TTM) | |
---|---|
Revenue | HK$82.29m |
Cost of Revenue | HK$40.28m |
Gross Profit | HK$42.01m |
Other Expenses | HK$33.56m |
Earnings | HK$8.45m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 0.011 |
Gross Margin | 51.05% |
Net Profit Margin | 10.27% |
Debt/Equity Ratio | 0% |
How did 8372 perform over the long term?
See historical performance and comparisonDividends
2.8%
Current Dividend Yield24%
Payout RatioCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/25 08:08 |
End of Day Share Price | 2024/12/24 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Grand Brilliance Group Holdings Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|